PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19
Clinical trial NCT05543707 · TERMINATED
Trial details
- NCT number
- NCT05543707
- Sponsor
- Pardes Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-21
- Primary completion
- 2023-01-27
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.